Welcome to MS Views and News blog

MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.

Categories

Latest Blog Posts

August 13, 2020

Your Brain Fog May Be an Anxiety Symptom — Here’s How to Deal with It

  • Additional MS resource sites
    /
  • Multiple Sclerosis
    /
  • Multiple Sclerosis (MS) Symptoms
    /
Click HERE to Subscribe for the MS Beacon Newsletter Brain fog describes a mental fuzziness or lack of clarity. When…
Additional MS resource sites

August 13, 2020

Relationships and Intimacy: When MS Gets In the Way

  • Additional MS resource sites
    /
  • Multiple Sclerosis
    /
Click HERE to Subscribe for the MS Beacon Newsletter By: Kathleen Healey, NP, PhD and Meghan Beier, PhD Up to…
Additional MS resource sites

August 12, 2020

Personal Social Networks Associated With Physical Function in Multiple Sclerosis

  • Additional MS resource sites
    /
Larger social network effective size correlated with better physical function, while network constraint correlated with worse physical function in those…
Additional MS resource sites

August 12, 2020

Bristol Myers Squibb and the Bristol Myers Squibb Foundation Commit $300 Million to Accelerate and Expand Health Equity and Diversity and Inclusion Efforts

  • Access to Care
    /
  • Accessibility
    /
  • Additional MS resource sites
    /
  • Medical Updates -Non MS Related
    /
  • Misc. MS Related
    /
Five–year commitment builds on long-standing investment in health equity Click HERE to Subscribe for the MS Beacon Newsletter Aug 12,…
Access to Care

August 11, 2020

Rituximab More Effective Than Gilenya, Tecfidera, and Comparable to Tysabri, Study Finds

  • MS Drug Therapies
    /
  • MS Relapse-Exacerbation
    /
  • MS Research Study and Reports
    /
  • Multiple Sclerosis
    /
AUGUST 11, 2020   BY MARTA FIGUEIREDO   Rituximab is more effective and leads to fewer treatment discontinuations in people with multiple sclerosis (MS) than Gilenya (fingolimod) and Tecfidera (dimethyl…
MS Drug Therapies

August 11, 2020

Things People Say When You Tell Them About Your Diagnosis

  • Multiple Sclerosis
    /
AUGUST 11, 2020  BY JESSIE ACE Click HERE to Subscribe for the MS Beacon Newsletter After you receive a diagnosis and are coming…
Multiple Sclerosis

August 11, 2020

See the MS Views and News LINK TREE

  • MS Views and News
    /
Click HERE to Subscribe for the MS Beacon Newsletter Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews…
MS Views and News

August 11, 2020

Jeffrey Cohen, MD: S1P Modulator Development in Multiple Sclerosis

  • MS Drug Therapies
    /
Click HERE to Subscribe for the MS Beacon Newsletter “The hope was that by developing more selective S1P modulators, that…
MS Drug Therapies

August 11, 2020

LDN Questions and Answers

  • Complementary & Alternative therapies and devices for Multiple Sclerosis (MS)
    /
Click HERE to Subscribe for the MS Beacon Newsletter LDN Questions and Answers  Answered by LDN Advisers and Medical Members.…
Complementary & Alternative therapies and devices for Multiple Sclerosis (MS)

August 11, 2020

IMU-838 could be alternative treatment option for RRMS patients who are ineligible with MAbs

  • MS Research Study and Reports
    /
Click HERE to Subscribe for the MS Beacon Newsletter Following the publication of positive top-line data from the Phase II EMPhASIS…
MS Research Study and Reports

Categories

Latest Blog Posts